Sequencing and Combining Immunotherapies in Melanoma
Howard L. Kaufman, MD, says that the oncology community is in its infancy in terms of selecting and sequencing immunotherapies for patients with melanoma.
Howard L. Kaufman, MD, Rush University Medical Center, says that the oncology community is in its infancy in terms of selecting and sequencing immunotherapies for patients with melanoma.
Kaufman says until researchers have a predictive biomarker to measure how a patient reacts, they have to use basic guidelines. T-VEC is a virus agent that can be administered in the office and has a good safety profile, with fatigue and fever being the most common side effects. For a patient to be eligible for T-VEC, their melanoma needs to be accessible for injection.
Clinical Pearls
Kaufman says that there is a lot of interest in combining immunotherapies and expanding immunologic response. There is currently a phase II study underway looking at the combination of T-VEC and ipilimumab.
- T-VEC has a minimal toxicity profile, with fatigue and fever being the most common side effects
- Combining immunotherapies may enhance responses
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
